Insider Transactions in Q4 2024 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.16%
|
$1,325,000
$53.58 P/Share
|
|
Oct 18
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,200,000
+11.41%
|
$52,800,000
$44.75 P/Share
|
|
Oct 18
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
801,751
-8.36%
|
$38,484,048
$48.74 P/Share
|
|
Oct 18
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
660,018
-8.36%
|
$31,680,864
$48.74 P/Share
|
|
Oct 17
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
1,843
-22.44%
|
$92,150
$50.02 P/Share
|
|
Oct 17
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,769
+5.41%
|
$35,380
$20.19 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
100,610
-22.05%
|
$5,030,500
$50.37 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,515
+15.35%
|
$210,300
$20.19 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
108,906
-1.6%
|
$5,445,300
$50.15 P/Share
|